174 related articles for article (PubMed ID: 33647541)
1. BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells.
Qi F; Yuan H; Chen Y; Guo Y; Zhang S; Liu Z; He W; Guo Z
J Inorg Biochem; 2021 May; 218():111394. PubMed ID: 33647541
[TBL] [Abstract][Full Text] [Related]
2. A New Approach to Sensitize Antitumor Monofunctional Platinum(II) Complexes via Short Time Photo-Irradiation.
Xue X; Zhu C; Chen H; Bai Y; Shi X; Jiao Y; Chen Z; Miao Y; He W; Guo Z
Inorg Chem; 2017 Apr; 56(7):3754-3762. PubMed ID: 28080031
[TBL] [Abstract][Full Text] [Related]
3. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
4. Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light.
Ramu V; Gautam S; Garai A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Feb; 57(4):1717-1726. PubMed ID: 29400953
[TBL] [Abstract][Full Text] [Related]
5. Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity.
Raza MK; Gautam S; Garai A; Mitra K; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Sep; 56(18):11019-11029. PubMed ID: 28846407
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
7. Highly Emissive Self-Assembled BODIPY-Platinum Supramolecular Triangles.
Zhou J; Zhang Y; Yu G; Crawley MR; Fulong CRP; Friedman AE; Sengupta S; Sun J; Li Q; Huang F; Cook TR
J Am Chem Soc; 2018 Jun; 140(24):7730-7736. PubMed ID: 29787269
[TBL] [Abstract][Full Text] [Related]
8. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
9. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
[TBL] [Abstract][Full Text] [Related]
10. BODIPY-doped silica nanoparticles with reduced dye leakage and enhanced singlet oxygen generation.
Wang Z; Hong X; Zong S; Tang C; Cui Y; Zheng Q
Sci Rep; 2015 Jul; 5():12602. PubMed ID: 26211417
[TBL] [Abstract][Full Text] [Related]
11. Highly Phototoxic Transplatin-Modified Distyryl-BODIPY Photosensitizers for Photodynamic Therapy.
Padrutt R; Babu V; Klingler S; Kalt M; Schumer F; Anania MI; Schneider L; Spingler B
ChemMedChem; 2021 Feb; 16(4):694-701. PubMed ID: 33164336
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light.
Jana A; Sahoo S; Paul S; Sahoo S; Jayabaskaran C; Chakravarty AR
Inorg Chem; 2024 Apr; 63(15):6822-6835. PubMed ID: 38560761
[TBL] [Abstract][Full Text] [Related]
13. Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.
Ramu V; Kundu P; Kondaiah P; Chakravarty AR
Inorg Chem; 2021 May; 60(9):6410-6420. PubMed ID: 33843212
[TBL] [Abstract][Full Text] [Related]
14. Photo-physical, theoretical and photo-cytotoxic evaluation of a new class of lanthanide(iii)-curcumin/diketone complexes for PDT application.
Musib D; Pal M; Raza MK; Roy M
Dalton Trans; 2020 Aug; 49(31):10786-10798. PubMed ID: 32779686
[TBL] [Abstract][Full Text] [Related]
15. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
17. Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy.
Kim C; Mai DK; Lee J; Jo J; Kim S; Badon IW; Lim JM; Kim HJ; Yang J
Nanoscale; 2024 May; 16(19):9462-9475. PubMed ID: 38639449
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
19. New BODIPYs for photodynamic therapy (PDT): Synthesis and activity on human cancer cell lines.
Caruso E; Malacarne MC; Marras E; Papa E; Bertato L; Banfi S; Gariboldi MB
Bioorg Med Chem; 2020 Nov; 28(21):115737. PubMed ID: 33065434
[TBL] [Abstract][Full Text] [Related]
20. New Selenonapthaquinone-Based Copper (II) Complexes as the Next-Generation Photochemotherapeutic Agents.
Devi LR; Raza MK; Musib D; Roy M
Anticancer Agents Med Chem; 2021; 21(1):33-41. PubMed ID: 32720606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
